Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0002008210-25-000001
Filing Date
2025-01-22
Accepted
2025-01-22 12:49:08
Documents
1
Effectiveness Date
2025-01-22
Items
Item 06c:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)
Item 3C.5: Section 3(c)(5)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 21778
  Complete submission text file 0002008210-25-000001.txt   23005
Mailing Address 300 CRESCENT COURT SUITE 700 DALLAS TX 75201
Business Address 300 CRESCENT COURT SUITE 700 DALLAS TX 75201 (833) 697-6246
NexPoint Life Sciences III DST (Filer) CIK: 0002008210 (see all company filings)

EIN.: 883907129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-503969 | Film No.: 25544799